During the past decade, Provena St. Mary's Regional Cancer Center - Kankakee conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 22 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Provena St. Mary's Regional Cancer Center - Kankakee" #1 sponsor was "SWOG Cancer Research Network" with 7 trials, followed by "Eastern Cooperative Oncology Group" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "NSABP Foundation Inc" with 5 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Provena St. Mary's Regional Cancer Center - Kankakee" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "Aptuit" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Provena St. Mary's Regional Cancer Center - Kankakee" are "Breast Cancer" (7 trials), "Lymphoma" (4 trials), "Colorectal Cancer" (3 trials), "Leukemia" (3 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Provena St. Mary's Regional Cancer Center - Kankakee" in a lesser frequency.

Most popular intervention types in "Provena St. Mary's Regional Cancer Center - Kankakee" are "Drug" (20 trials), "Biological" (11 trials), "Other" (6 trials), "Radiation" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (7 trials), "doxorubicin hydrochloride" (4 trials), "rituximab" (4 trials), "bevacizumab" (3 trials) and "cetuximab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Provena St. Mary's Regional Cancer Center - Kankakee" are 16 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Provena St. Mary's Regional Cancer Center - Kankakee". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Provena St. Mary's Regional Cancer Center - Kankakee, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Provena St. Mary's Regional Cancer Center - Kankakee, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".